Formulary Watch Spotlights
Product Profile: LYNOZYFIC (linvoseltamab-gc)
Product Profile: LIBTAYO (cemiplimab)
Product Profile: JASCAYD (nerandomilast)
Product Profile: JOURNAVX (suzetrigine)
Product Profile: MONJUVI (tafasitamab-cxix injection, for intravenous use)
Product Profile: ZYNYZ (retifanlimab-dlwr injection, for intravenous use)
Product Profile: REXULTI (brexpiprazole tablet)
Product Profile: MIEBO (perfluorohexyloctane ophthalmic solution)
Product Profile: EYELEA HD (aflibercept injection, solution)
Product Profile: TARPEYO (budesonide capsule, delayed release)
Product Profile: WINREVAIR (sotatercept-csrk, for injection, for subcutaneous use)
Product Profile: XDEMVY (lotilaner ophthalmic solution)
Product Profile: ABILIFY ASIMTUFII (aripiprazole injection, suspension, extended release)
Product Profile: AREXVY (respiratory syncytial virus vaccine, adjuvanted)
Product Profile: ABRYSVO (respiratory syncytial virus vaccine)
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
What exactly is managed care today?
3
TrumpRx launches; some experts question its long-term value
4
PBM reform. It has finally happened
5